1.37
price up icon4.58%   0.06
pre-market  시장 영업 전:  1.39   0.02   +1.46%
loading
전일 마감가:
$1.31
열려 있는:
$1.34
하루 거래량:
32,214
Relative Volume:
0.07
시가총액:
$3.14M
수익:
$35.75M
순이익/손실:
$11.57M
주가수익비율:
-0.3599
EPS:
-3.8069
순현금흐름:
$-26.25M
1주 성능:
-4.86%
1개월 성능:
-19.88%
6개월 성능:
-67.76%
1년 성능:
-84.81%
1일 변동 폭
Value
$1.32
$1.37
1주일 범위
Value
$1.275
$1.48
52주 변동 폭
Value
$1.06
$12.50

레드힐 바이오파마 ADR Stock (RDHL) Company Profile

Name
명칭
Redhill Biopharma Ltd Adr
Name
전화
-
Name
주소
-
Name
직원
35
Name
트위터
@RedHillBio
Name
다음 수익 날짜
2025-08-19
Name
최신 SEC 제출 서류
Name
RDHL's Discussions on Twitter

RDHL을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Drug Manufacturers - Specialty & Generic icon
RDHL
Redhill Biopharma Ltd Adr
1.37 3.31M 35.75M 11.57M -26.25M -3.8069
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
155.10 67.51B 9.39B 2.62B 2.22B 5.81
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
15.07 47.88B 29.96B 957.25M 4.77B 0.304
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.675 43.42B 14.26B 1.98B 2.47B 0.4347
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
18.12 20.72B 16.70B -157.13M 1.19B -0.155
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
305.38 14.21B 2.99B 1.21B 1.13B 25.06

레드힐 바이오파마 ADR Stock (RDHL) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2021-08-31 개시 Cantor Fitzgerald Overweight
2021-05-18 개시 H.C. Wainwright Buy
2020-09-11 개시 BTIG Research Buy
2019-07-12 업그레이드 WBB Securities Buy → Strong Buy
2019-03-12 업그레이드 WBB Securities Speculative Buy → Buy
2018-01-26 개시 Nomura Buy
2017-10-06 개시 Seaport Global Securities Buy
2017-10-04 재확인 H.C. Wainwright Buy
2017-02-24 재확인 FBR & Co. Outperform
2016-07-27 재확인 FBR Capital Outperform
2015-09-29 개시 Nomura Buy
2015-07-29 재확인 ROTH Capital Buy
2015-06-17 재확인 H.C. Wainwright Buy
2015-06-15 재확인 ROTH Capital Buy
모두보기

레드힐 바이오파마 ADR 주식(RDHL)의 최신 뉴스

pulisher
Aug 14, 2025

RedHill Biopharma receives Nasdaq extension to regain compliance by October - Investing.com South Africa

Aug 14, 2025
pulisher
Jul 21, 2025

Redhill Biopharma stock soars after FDA provides positive pathway for Crohn’s drug - Investing.com India

Jul 21, 2025
pulisher
Apr 22, 2025

Taking the lead: Redhill Biopharma Ltd. ADR (RDHL) - Sete News

Apr 22, 2025
pulisher
Apr 22, 2025

The time has not yet come to remove your chips from the table: Hertz Global Holdings Inc (HTZ) - Sete News

Apr 22, 2025
pulisher
Apr 22, 2025

A significant driver of top-line growth: Alexandria Real Estate Equities Inc (ARE) - Sete News

Apr 22, 2025
pulisher
Apr 22, 2025

Redhill Biopharma Ltd. ADR [RDHL] Insider Activity: An Update for Investors - knoxdaily.com

Apr 22, 2025
pulisher
Apr 17, 2025

RedHill Biopharma faces Nasdaq non-compliance issue - Investing.com

Apr 17, 2025
pulisher
Apr 17, 2025

RedHill Biopharma faces Nasdaq non-compliance issue By Investing.com - Investing.com India

Apr 17, 2025
pulisher
Apr 16, 2025

Redhill Biopharma stock hits 52-week low at $1.72 amid market challenges - Investing.com

Apr 16, 2025
pulisher
Apr 02, 2025

Redhill Biopharma stock hits 52-week low at $2.47 amid steep annual decline - Investing.com

Apr 02, 2025
pulisher
Mar 18, 2025

RedHill Biopharma targets UK approval for H. pylori therapy - Investing.com India

Mar 18, 2025
pulisher
Mar 18, 2025

RedHill Biopharma targets UK approval for H. pylori therapy By Investing.com - Investing.com South Africa

Mar 18, 2025
pulisher
Mar 12, 2025

Redhill Biopharma Ltd. ADR (RDHL)’s Stock Price Falls Due To Weak Fundamental Momentum - Marketing Sentinel

Mar 12, 2025
pulisher
Mar 11, 2025

Redhill Biopharma stock hits 52-week low at $3 amid steep annual decline By Investing.com - Investing.com South Africa

Mar 11, 2025
pulisher
Mar 11, 2025

Redhill Biopharma stock hits 52-week low at $3 amid steep annual decline - Investing.com

Mar 11, 2025
pulisher
Feb 25, 2025

What Did We Note About Insider Trading At Redhill Biopharma Ltd. ADR (NASDAQ: RDHL)? - Stocks Register

Feb 25, 2025
pulisher
Feb 25, 2025

Hyloris secures global rights to RedHill’s RHB-102 - Investing.com India

Feb 25, 2025
pulisher
Feb 21, 2025

Redhill Biopharma stock hits 52-week low at $4.79 - Investing.com India

Feb 21, 2025
pulisher
Feb 04, 2025

RedHill tests opaganib with Bayer's drug in prostate cancer study - Investing.com

Feb 04, 2025
pulisher
Jan 21, 2025

RedHill stock rises on expanded Medicare coverage By Investing.com - Investing.com South Africa

Jan 21, 2025
pulisher
Dec 02, 2024

RedHill wins $8 million judgment in New York court - Investing.com

Dec 02, 2024
pulisher
Aug 16, 2024

RedHill Biopharma Announces Plan to Implement ADS Ratio Change - PR Newswire

Aug 16, 2024
pulisher
Jul 22, 2024

RedHill Biopharma finalizes agreement to enhance cash position - Investing.com

Jul 22, 2024
pulisher
Jan 11, 2024

Balancing Acidity: Exploring the Proton Pump Inhibitors Market - openPR.com

Jan 11, 2024
pulisher
Nov 29, 2023

symbol__ Stock Quote Price and Forecast - CNN

Nov 29, 2023
pulisher
Aug 01, 2023

RedHill Biopharma Announces Talicia Approved in the United Arab Emirates and First Commercial Order Outside the U.S. - Barchart.com

Aug 01, 2023
pulisher
Jul 21, 2023

RedHill Biopharma Announces Registered Direct Offering and Warrant Exercise for $3.8 Million Gross Proceeds - Barchart.com

Jul 21, 2023
pulisher
Mar 17, 2023

RedHill Biopharma to Implement ADS Ratio Change to 1:400 By Investing.com - Investing.com India

Mar 17, 2023
pulisher
Feb 24, 2023

Why Beyond Meat Shares Are Trading Higher By 14%; Here Are 20 Stocks Moving Premarket - markets.businessinsider.com

Feb 24, 2023
pulisher
Nov 08, 2022

Extremely Robust COVID-19 Clinical Trial Pipeline With 420+ Key Companies Expected to Change the Pace of the COVID-19 Treatment - PR Newswire UK

Nov 08, 2022
pulisher
Jun 21, 2022

Cathie Wood Predictions 2022 - New Trader U

Jun 21, 2022
pulisher
Jan 11, 2021

RedHill's Partner Cosmo Pharmaceuticals Successfully Completes Phase 2 Study of Rifamycin SV-MMX 600mg in IBS-D - PR Newswire

Jan 11, 2021
pulisher
Jan 21, 2020

RedHill Biopharma to Focus Commercial Efforts on Talicia® - GlobeNewswire

Jan 21, 2020
pulisher
May 28, 2019

RedHill Biopharma: TALICIA Launch For H. Pylori In Sight - Investing.com

May 28, 2019
pulisher
Sep 04, 2018

RedHill Biopharma's Drug Pipeline May Merit Substantial Upside, And Potential Catalysts Are On The Horizon - Seeking Alpha

Sep 04, 2018
pulisher
Jul 15, 2015

RedHill Biopharma files for further Nasdaq offering - גלובס

Jul 15, 2015
pulisher
Jun 16, 2015

Redhill Biopharma (RDHL) Stock Price, News & Analysis - MarketBeat

Jun 16, 2015

레드힐 바이오파마 ADR (RDHL) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$29.00
price down icon 2.52%
$17.79
price down icon 0.67%
drug_manufacturers_specialty_generic RDY
$14.46
price down icon 0.34%
$10.55
price down icon 0.94%
$133.99
price down icon 1.06%
$305.38
price down icon 2.19%
자본화:     |  볼륨(24시간):